| Journal: | Revista de investigación clínica |
| Database: | PERIÓDICA |
| System number: | 000390714 |
| ISSN: | 0034-8376 |
| Authors: | Hernández González, Martha1 Solorio, Sergio2 Solís Jiménez, Manuel Crisóstomo2 Rodríguez Mariscal, Leticia2 Murillo Ortiz, Blanca2 Vazquez Olvera, Sergio2 |
| Institutions: | 1Instituto Mexicano del Seguro Social, Hospital General de Zona 21, León, Guanajuato. México 2Instituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad 1, León, Guanajuato. México |
| Year: | 2015 |
| Season: | May-Jun |
| Volumen: | 67 |
| Number: | 3 |
| Pages: | 199-206 |
| Country: | México |
| Language: | Inglés |
| Document type: | Estadística o encuesta |
| Approach: | Analítico |
| English abstract | The metabolic syndrome increases cardiovascular mortality. We report the mid-term prognostic value of dobutamine echocardiography for metabolic syndrome. Patients and methods: A dobutamine echocardiography protocol was performed in patients aged 18 years of age or older who suffered from chest pain and who were followed-up for two years. The patients were divided in two groups, with and without metabolic syndrome. Statistical analyses were performed using ROC curves and survival analysis; the Begg-Greenes method was used to correct for verification bias. We included 128 patients, 66 with metabolic syndrome and 62 without. Results: Forty-one patients with metabolic syndrome and 36 without had positive dobutamine echocardiography test results (p = 0.77). Coronary artery disease was found in 27 patients with metabolic syndrome and in 29 without metabolic syndrome; percutaneous revascularization was required in 24 and 26 patients, respectively (p = 0.29). Cardiovascular events occurred in 28 patients during follow-up (19 in metabolic syndrome vs. 9 in non-metabolic syndrome; p = 0.17). The odds ratio of major cardiovascular events in the metabolic syndrome group was 5.8 (95% CI: 1.74-19.60); in the control group it was 8.6 (95% CI: 2.53-29.59). Conclusion: Dobutamine echocardiography for metabolic syndrome has high sensitivity but is not a determining factor for mid-term prognosis |
| Disciplines: | Medicina |
| Keyword: | Diagnóstico, Metabolismo y nutrición, Sistema cardiovascular, Síndrome metabólico, Ecocardiografía, Dobutamina, Enfermedad coronaria, Pruebas diagnósticas, Valor pronóstico |
| Keyword: | Medicine, Cardiovascular system, Diagnosis, Metabolism and nutrition, Metabolic syndrome, Echocardiography, Dobutamine, Coronary artery disease, Diagnostic tests, Prognostic factors |
| Full text: | Texto completo (Ver PDF) |
